Iran war has not disrupted pharma supply chains. That could change if conflict is prolonged
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but it could eventually — affecting prices.
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but it could eventually — affecting prices.
Today's biotech news includes the Medicare director offering a tempered view of TrumpRx and high-dose Wegovy getting an FDA nod.
Kolkata: The West Bengal Clinical Establishment Regulatory Commission (WBCERC) has directed the Directorate of Health Services (DHS) to constitute a high-level committee to scrutinise a bill issued by a private…
Following successful appeals from drugmakers, the U.K. is taking another look at whether two new Alzheimer's drugs can be considered cost-effective.
New Delhi: The Supreme Court of India has ruled that when deciding the reliability of a dying declaration, the opinion of the treating doctor holds more weight than that of…
New Delhi: Upholding the State Commission's order that found no medical negligence, the National Consumer Disputes Redressal Commission (NCDRC) dismissed an appeal filed against Apollo Hospitals in a case related…
Mumbai: The State Common Entrance Test (CET) Cell has extended the registration deadline for MH-Nursing CET 2026, offering fresh relief to candidates who missed the earlier online registration dates. The…
New Delhi- The Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr Ram Manohar Lohia (RML) Hospital have issued an official admission notice detailing the reporting schedule for candidates…
Bhubaneswar: In a tragic incident that has sparked public outrage, the district administration of Jagatsinghpur sealed a private hospital on Thursday following the death of a pregnant woman, allegedly due…
Looking to bolster its pipeline, Novartis is buying a breast cancer drug candidate for $2 billion from Delaware-based Synnovation Therapeutics.